Abingdon Health (LON:ABDX) Releases Quarterly Earnings Results

Abingdon Health (LON:ABDX – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported GBX (0.51) EPS for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Price Performance

LON:ABDX traded up GBX 0.05 during trading hours on Thursday, reaching GBX 9.05. The stock had a trading volume of 571,644 shares, compared to its average volume of 237,414. The company has a 50 day moving average price of GBX 10.70 and a two-hundred day moving average price of GBX 10.53. Abingdon Health has a 52 week low of GBX 5.50 and a 52 week high of GBX 13. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91. The stock has a market capitalization of £22.87 million, a PE ratio of -11.17 and a beta of 0.13.

Get Abingdon Health alerts:

Abingdon Health Company Profile

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.

See Also

• Five stocks we like better than Abingdon Health
• Beyond the GPU: Credo Paves the Next AI Data Superhighway
• Fastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure
• Synopsys Signals Confidence With $1B Accelerated Buyback, Analysts Raise Targets
• Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But Up

Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.